SYNAGIS
100MG/1ML INJ SOL 1X1ML
| SÚKL code | 0210115 |
|---|---|
| Name of the product | SYNAGIS |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | SYNAGIS |
| Supplement | 100MG/1ML INJ SOL 1X1ML |
| Strenght | 100MG/1ML |
| Pharmaceutical form | Solution for injection |
| Package | 1X1ML |
| Route | Intramuscular use |
| Wrap type | Vial |
| Legal status | na lékařský předpis |
| Active substance | PALIVIZUMAB (PALIVIZUMABUM) |
| ATC group | J06BB16 |
| ATC group name | PALIVIZUMAB |
Marketing authorisation information
| Registration Number | EU/1/99/117/004 |
|---|---|
| Type of MA | centralised without orphans |
| MA status | R - active MA/authorised medicinal product |
| MA Holder | AstraZeneca AB, Södertälje |
| MA Holder country | ŠVÉDSKO |
cz